Related references
Note: Only part of the references are listed.Association between change in plasma triglyceride levels and risk of stroke and carotid atherosclerosis - Systematic review and meta-regression analysis
Julien Labreuche et al.
ATHEROSCLEROSIS (2010)
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
Eric Bruckert et al.
ATHEROSCLEROSIS (2010)
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
Min Jun et al.
LANCET (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of Fibrates on Lipid Profiles and Cardiovascular Outcomes: A Systematic Review
Samuel Abourbih et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Peroxisome proliferator-activated receptor-alpha (PPARα): At the crossroads of obesity, diabetes and cardiovascular disease
Jean-Charles Fruchart
ATHEROSCLEROSIS (2009)
Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Russell Scott et al.
DIABETES CARE (2009)
Gender differences in the lipid profile of dyslipidemic subjects
Genovefa D. Kolovou et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis
Matthias Briel et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
The Residual Risk Reduction Initiative: a call to action to residual vascular risk in dyslipidaemic patients
Jean-Charles Fruchart et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study
G. Assmann et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study
G. Assmann et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
The role of fibrates in the prevention of cardiovascular disease-a pooled meta-analysis of long-term randomized placebo-controlled clinical trials
Sandeep Ajoy Saha et al.
AMERICAN HEART JOURNAL (2007)
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Sandeep Bansal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Borge G. Nordestgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Triglycerides and the risk of coronary heart disease - 10 158 incident cases among 262 525 participants in 29 Western prospective studies
Nadeem Sarwar et al.
CIRCULATION (2007)
Dyslipidaemia and global cardiovascular risk: clinical issues
Gerd Assmann
EUROPEAN HEART JOURNAL SUPPLEMENTS (2006)
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
Christopher P. Cannon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial
A Keech et al.
LANCET (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Differential effects of lipid-lowering therapies on stroke prevention - A meta-analysis of randomized trials
JC Corvol et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Bezafibrate in men with lower extremity arterial disease: randomised controlled trial
T Meade et al.
BRITISH MEDICAL JOURNAL (2002)
Relation of gemfibrozil treatment and lipid levels with major coronary events - VA-HIT: A randomized controlled trial
SJ Robins et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease - The bezafibrate infarction prevention (BIP) study
Z Schlesinger et al.
CIRCULATION (2000)
Share Paper
